53 signals · alpha_vantage, bluesky, Hacker News +2 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Low-to-moderate risk signals with no major red flags in current data.
Auto-generated from public signals — AI summary pending. Based on 4 recent signals.
A U.S. appeals court on Monday revived a lawsuit brought by generic drugmaker Teva Pharmaceuticals that accuses Eli Lilly of breaching a settlement agreement that allowed Teva to market a generic version of Lilly's osteoporosis drug Forteo.
appeals court on Monday revived a lawsuit brought by generic drugmaker Teva Pharmaceuticals that accuses Eli Lilly of breaching a settlement agreement that allowed Teva to market a generic version of Lilly's osteoporosis drug Forteo.
Ah, it's time to collect data from the experimental obesity treatment retatrutide, which is currently in development by Eli Lilly. Eli Lilly and the U.S. Food and Drug Administration granted extraordinary pre-approval access to a 79 yo single patient through the agency's "compassionate use" program.
Food and Drug Administration granted extraordinary pre-approval access to a 79 yo single patient through the agency's "compassionate use" program.
Biopharmaceutical company focusing on diabetes and oncology.
Based on 53 signals across 5 sources · snapshot 13 Jul 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Eli Lilly is mixed based on public signals as of 13 Jul 2026.
Based on 53 signals across 5 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
Pharmaceuticals industry average
Hims & Hers jumps 7% after expanding partnership with Eli Lilly Yahoo Finance